181 related articles for article (PubMed ID: 36966452)
1. Metformin mitigates renal dysfunction in obese insulin-resistant rats via activation of the AMPK/PPARα pathway.
Thongnak L; Pengrattanachot N; Promsan S; Phengpol N; Sutthasupha P; Jaikumkao K; Lungkaphin A
Arch Pharm Res; 2023 May; 46(5):408-422. PubMed ID: 36966452
[TBL] [Abstract][Full Text] [Related]
2. Renal outcomes with sodium glucose cotransporter 2 (SGLT2) inhibitor, dapagliflozin, in obese insulin-resistant model.
Jaikumkao K; Pongchaidecha A; Chueakula N; Thongnak L; Wanchai K; Chatsudthipong V; Chattipakorn N; Lungkaphin A
Biochim Biophys Acta Mol Basis Dis; 2018 Jun; 1864(6 Pt A):2021-2033. PubMed ID: 29572114
[TBL] [Abstract][Full Text] [Related]
3. High-fat diet-induced renal cell apoptosis and oxidative stress in spontaneously hypertensive rat are ameliorated by fenofibrate through the PPARα-FoxO3a-PGC-1α pathway.
Chung HW; Lim JH; Kim MY; Shin SJ; Chung S; Choi BS; Kim HW; Kim YS; Park CW; Chang YS
Nephrol Dial Transplant; 2012 Jun; 27(6):2213-25. PubMed ID: 22076434
[TBL] [Abstract][Full Text] [Related]
4. Metformin decreases high-fat diet-induced renal injury by regulating the expression of adipokines and the renal AMP-activated protein kinase/acetyl-CoA carboxylase pathway in mice.
Kim D; Lee JE; Jung YJ; Lee AS; Lee S; Park SK; Kim SH; Park BH; Kim W; Kang KP
Int J Mol Med; 2013 Dec; 32(6):1293-302. PubMed ID: 24068196
[TBL] [Abstract][Full Text] [Related]
5. Atorvastatin attenuates obese-induced kidney injury and impaired renal organic anion transporter 3 function through inhibition of oxidative stress and inflammation.
Pengrattanachot N; Cherngwelling R; Jaikumkao K; Pongchaidecha A; Thongnak L; Swe MT; Chatsudthipong V; Lungkaphin A
Biochim Biophys Acta Mol Basis Dis; 2020 Jun; 1866(6):165741. PubMed ID: 32101757
[TBL] [Abstract][Full Text] [Related]
6. Metformin Improves Metabolic Memory in High Fat Diet (HFD)-induced Renal Dysfunction.
Tikoo K; Sharma E; Amara VR; Pamulapati H; Dhawale VS
J Biol Chem; 2016 Oct; 291(42):21848-21856. PubMed ID: 27551045
[TBL] [Abstract][Full Text] [Related]
7. Ping-tang Recipe () improves insulin resistance and attenuates hepatic steatosis in high-fat diet-induced obese rats.
Yang SY; Zhao NJ; Li XJ; Zhang HJ; Chen KJ; Li CD
Chin J Integr Med; 2012 Apr; 18(4):262-8. PubMed ID: 22457136
[TBL] [Abstract][Full Text] [Related]
8. Protectin DX ameliorates palmitate- or high-fat diet-induced insulin resistance and inflammation through an AMPK-PPARα-dependent pathway in mice.
Jung TW; Kim HC; Abd El-Aty AM; Jeong JH
Sci Rep; 2017 May; 7(1):1397. PubMed ID: 28469249
[TBL] [Abstract][Full Text] [Related]
9.
Lee HA; Cho JH; Afinanisa Q; An GH; Han JG; Kang HJ; Choi SH; Seong HA
Nutrients; 2020 Oct; 12(11):. PubMed ID: 33142995
[No Abstract] [Full Text] [Related]
10. Metformin treatment reverses high fat diet- induced non-alcoholic fatty liver diseases and dyslipidemia by stimulating multiple antioxidant and anti-inflammatory pathways.
Yasmin T; Rahman MM; Khan F; Kabir F; Nahar K; Lasker S; Islam MD; Hossain MM; Hasan R; Rana S; Alam MA
Biochem Biophys Rep; 2021 Dec; 28():101168. PubMed ID: 34825068
[TBL] [Abstract][Full Text] [Related]
11. Palmitoleic Acid Improves Metabolic Functions in Fatty Liver by PPARα-Dependent AMPK Activation.
de Souza CO; Teixeira AAS; Biondo LA; Lima Junior EA; Batatinha HAP; Rosa Neto JC
J Cell Physiol; 2017 Aug; 232(8):2168-2177. PubMed ID: 27925195
[TBL] [Abstract][Full Text] [Related]
12. Eburicoic Acid, a Triterpenoid Compound from Antrodia camphorata, Displays Antidiabetic and Antihyperlipidemic Effects in Palmitate-Treated C2C12 Myotubes and in High-Fat Diet-Fed Mice.
Lin CH; Kuo YH; Shih CC
Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29099085
[TBL] [Abstract][Full Text] [Related]
13. Salidroside inhibits insulin resistance and hepatic steatosis by downregulating miR-21 and subsequent activation of AMPK and upregulation of PPARα in the liver and muscles of high fat diet-fed rats.
Almohawes ZN; El-Kott A; Morsy K; Shati AA; El-Kenawy AE; Khalifa HS; Elsaid FG; Abd-Lateif AM; Abu-Zaiton A; Ebealy ER; Abdel-Daim MM; Ghanem RA; Abd-Ella EM
Arch Physiol Biochem; 2024 Jun; 130(3):257-274. PubMed ID: 35061559
[TBL] [Abstract][Full Text] [Related]
14. [Electroacupuncture improves glucose and lipid metabolism by regulating APN/AMPK/PPARα signaling of skeletal muscle in Zucker diabetic obese rats].
Duan HR; Li R; Song SS; Hu SQ; Zhuang ST; Li QY
Zhen Ci Yan Jiu; 2021 Nov; 46(11):907-13. PubMed ID: 34865326
[TBL] [Abstract][Full Text] [Related]
15. Sex differences in obesity-induced renal lipid accumulation revealed by lipidomics: a role of adiponectin/AMPK axis.
Juszczak F; Pierre L; Decarnoncle M; Jadot I; Martin B; Botton O; Caron N; Dehairs J; Swinnen JV; Declèves AE
Biol Sex Differ; 2023 Sep; 14(1):63. PubMed ID: 37770988
[TBL] [Abstract][Full Text] [Related]
16. Crataegus aronia prevents high-fat diet-induced hepatic steatosis in rats by activating AMPK-induced suppression of SREBP1 and activation of PPARα.
Shatoor AS; Al Humayed S; Almohiy HM
J Food Biochem; 2021 Nov; 45(11):e13945. PubMed ID: 34585409
[TBL] [Abstract][Full Text] [Related]
17. Fibroblast growth factor 21 protects against lipotoxicity-induced pancreatic β-cell dysfunction via regulation of AMPK signaling and lipid metabolism.
Xie T; So WY; Li XY; Leung PS
Clin Sci (Lond); 2019 Oct; 133(19):2029-2044. PubMed ID: 31654570
[TBL] [Abstract][Full Text] [Related]
18. The PPARβ/δ activator GW501516 prevents the down-regulation of AMPK caused by a high-fat diet in liver and amplifies the PGC-1α-Lipin 1-PPARα pathway leading to increased fatty acid oxidation.
Barroso E; Rodríguez-Calvo R; Serrano-Marco L; Astudillo AM; Balsinde J; Palomer X; Vázquez-Carrera M
Endocrinology; 2011 May; 152(5):1848-59. PubMed ID: 21363937
[TBL] [Abstract][Full Text] [Related]
19. LB100 ameliorates nonalcoholic fatty liver disease
Chen XY; Cai CZ; Yu ML; Feng ZM; Zhang YW; Liu PH; Zeng H; Yu CH
World J Gastroenterol; 2019 Dec; 25(45):6607-6618. PubMed ID: 31832001
[TBL] [Abstract][Full Text] [Related]
20. Monascin and ankaflavin act as natural AMPK activators with PPARα agonist activity to down-regulate nonalcoholic steatohepatitis in high-fat diet-fed C57BL/6 mice.
Hsu WH; Chen TH; Lee BH; Hsu YW; Pan TM
Food Chem Toxicol; 2014 Feb; 64():94-103. PubMed ID: 24275089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
